✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
The case we described here is the sixth case of clinically diagnosed acute pancreatitis.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Sorafenib is an inhibitor of multikinase proteins which is used for metastatic renal cell carcinoma and advanced stage hepatocellular carcinoma.
📊
Temel Bulgular & Veri:Its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely.
💡
Sonuç & Katkı:The case we described here is the sixth case of clinically diagnosed acute pancreatitis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Hepatocellular carcinoma · Pancreatitis · Sorafenib
Abstract
Sorafenib is an inhibitor of multikinase proteins which is used for metastatic renal cell carcinoma and advanced stage hepatocellular carcinoma. Its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely. Five cases of acute pancreatitis have been reported in literature until date. The case we described here is the sixth case of clinically diagnosed acute pancreatitis.
🔖
Bu Makaleye Atıf Yap
EMİNLER, A. T., IRAK, K., GULTEN, M., DOLAR, E., NAK, S. G., YİLDİRİM, C., AYDİN, T., AYYİLDİZ, T., KİYİCİ, M., GUREL, S. (2022). Sorafenib-induced pancreatitis. Journal of Experimental and Clinical Medicine, Cilt: 32 - Sayı: 3, 133–135. https://ajindex.com/articles/563092